Loading chat...

TN HB2220

Bill

Status

Passed

5/8/2018

Primary Sponsor

Cameron Sexton

Click for details

Origin

House of Representatives

110th General Assembly

AI Summary

Legislative Description

As enacted, authorizes a pharmaceutical manufacturer or its representatives to engage in truthful promotion of off-label uses. - Amends TCA Title 4; Title 7; Title 33; Title 53; Title 63; Title 68 and Title 71.

Drugs, Prescription

Last Action

Pub. Ch. 893

5/8/2018

Committee Referrals

Calendar and Rules3/6/2018
Health2/28/2018
Health Subcommittee2/14/2018
Health2/5/2018

Full Bill Text

No bill text available